References
- Pellicer A., Lightman A., Diamond M. P., Russel J. B., DeCherney A. H. Outcome of in vitro fertilization in women with low response to ovarian stimulation. Fertil. SteriL 1987; 47: 812–15
- Bergh C., Hillensjo T., Wikland M., Nilsson L., Borg G., Hamberger L. Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertil. SteriL 1994; 62: 113–20
- Feldberg D., Fahri J., Ashkenazi J., Dicker D., Shalev J., Ben-Rafael A. Minidose gonatropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil. SteriL 1994; 62: 343–6
- Baird D. T., Howies C. M. Induction of ovulation with gonadotrophins: hMG versus purified FSH. Ovulation Induction: Basic Science and Clinical Advances, M. Filicori, C. Flamigni. Elsevier Science B.V., Amsterdam 1994; 135–43
- Smitz J., Devroey P., Camus M., Deschacht J., van Waesberghe L., Wisanto A., van Steirtighem A. C. Inhibition of gonadotropic and ovarian function by intranasal administration of D-Ser (TBU)6-EA10-LHRH in normo-ovulatory women and patients with polycystic ovary disease. J. Endocrinol. Invest. 1988; 11: 74–9